Product Details
Product Name:
Mirvetuximab |
CAS No.:
1453084-36-0 |
Purity:
> 95% |
Supply Ability:
10g |
Release date:
2024/11/15 |
Product Introduction
Bioactivity
名稱 | Mirvetuximab |
描述 | Mirvetuximab (M9346A) is a novel folate receptor α (FRα) monoclonal antibody targeting anti-FOLR1 (folate receptor 1). Mirvetuximab soravtansine is often conjugated with platinum compounds or other compounds to form antibody-drug conjugates for the treatment of ovarian cancer and other FRα-positive cancers. |
存儲條件 | store at low temperature | store at -80°C | Shipping with blue ice. |
關(guān)鍵字 | Mirvetuximab |
相關(guān)產(chǎn)品 | Pemetrexed | Methotrexate | Folinic acid | Levomefolate calcium | Levoleucovorin Calcium | Trimethoprim | Folinic acid calcium | Pyrimethamine | Diaveridine | Pemetrexed disodium | Folinic Acid Calcium Salt Pentahydrate | Trimethoprim lactate |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:15231-91-1
$39.00 / 1mL
-
CAS:13204-98-3
$29.00 / 25mg
-
CAS:183204-72-0
$43.00 / 5mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$3180.00/5mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-10-23 |